Contact A Lawyer
Near You

Contact us today for a complimentary consultation with a qualified attorney near you.

Primary Pulmonary Hypertension Attorney

A Primary Pulmonary Hypertension attorney is a legal professional who represents individuals who have developed this serious life threatening condition as a result of prescription drug use. A Primary Pulmonary Hypertension attorney knows the laws applicable to an individual's case and can use this knowledge to determine how best to protect and maximize their legal interests. Compensation for medical expenses, out-of-pocket expenses, emotional suffering, loss of income, and the like may be sought through a personal injury lawsuit with the professional help of a Primary Pulmonary Hypertension attorney.

The prescription diet drugs, Pondimin and Redux, popularly known as Fen Phen, were pulled from the market on September 15, 1997. Wyeth (a division of American Home Products Corporation), the drug's maker, pulled the drug from the shelves under FDA orders after studies discovered that Fen Phen use drastically increased a patient's risk of developing the deadly cardiovascular condition known as Primary Pulmonary Hypertension (PPH). At least 100 cases of PPH in Fen Phen users were discovered prior to the recall of this dangerously defective drug. It is estimated that six to seven million Americans took a Fen Phen product before this drug was pulled from the market.

Promptly after the recall, thousands of Fen Phen users came forward with similar PPH injuries. To file civil cases for these victims of Fen Phen, numerous Primary Pulmonary Hypertension attorneys answered the call to provide consumer legal protection. These Primary Pulmonary Hypertension attorneys represented thousands of victims who developed PPH or related valvular injuries as a result of Fen Phen use.

These Primary Pulmonary Hypertension attorneys helped the many victims seek relief for medical testing, treatment, and other expenses; loss of income due to this progressive and debilitating condition, and more. The cost of treating a patient diagnosed with Primary Pulmonary Hypertension can reach upwards of $500,000 or more depending on the treatment necessary to manage this condition. There is no known cure for PPH and most patients live an average of only 30 months after being diagnosed.

Though the defective drugs were pulled from the shelves years ago, Primary Pulmonary Hypertension attorneys continue to help those victims of this fatal condition whose cases have not yet been legally addressed. Some individuals who took Fen Phen are just now being diagnosed with heart valve damage and PPH from Fen Phen use. In 2002, the New York Times published data revealing that only one-third of the most serious Primary Pulmonary Hypertension cases have been addressed by the compensation settlement trust established by Wyeth soon after the recall and a flood of litigation.

As recently as January 2005, Wyeth announced that they would be increasing their estimates for the total cost of Fen Phen litigation to $21.1 billion. Primary Pulmonary Hypertension attorneys are still taking cases to help the victims of Fen Phen's deadly side effects. Please contact us to speak with a qualified and experienced Primary Pulmonary Hypertension attorney who can evaluate your case.

Contact a Fenphen Recall Lawyer

More Fenphen Resources

Pulmonary Hypertension Resource - News, Information and Resources regarding Primary Pulmonary Hypertension and other forms of Severe Pulmonary Hypertension.

Pulmonary Hypertension Association - Features association background, disease and treatment information, news, research, and message boards.